Prostate Cancer(PC)Market Global Analysis and Forecasts 2021 - PowerPoint PPT Presentation

About This Presentation
Title:

Prostate Cancer(PC)Market Global Analysis and Forecasts 2021

Description:

Prostate Cancer (PC) is a disease predominately of the elderly with 60% of cases diagnosed in men aged 65 or over. Prostate cancer is slow growing, and asymptomatic at its earliest stages. – PowerPoint PPT presentation

Number of Views:39

less

Transcript and Presenter's Notes

Title: Prostate Cancer(PC)Market Global Analysis and Forecasts 2021


1
Prostate Cancer Market to 2021 - Increasing
Disease Prevalence to be a Key Driver of Market
Growth
Published on - 01 November, 2015 Number of
pages 164 Single User Price 4995
Prostate Cancer (PC) is a disease predominately
of the elderly with 60 of cases diagnosed in men
aged 65 or over. Prostate cancer is slow growing,
and asymptomatic at its earliest stages. However,
with the use of digital rectal examination, the
PSA test, and the incidental discovery of tumors
following resection of the prostate, the majority
of PC cases are diagnosed at an early stage
(60).
2
Prostate Cancer (PC) is a disease predominately
of the elderly with 60 of cases diagnosed in men
aged 65 or over. Prostate cancer is slow growing,
and asymptomatic at its earliest stages. However,
with the use of digital rectal examination, the
PSA test, and the incidental discovery of tumors
following resection of the prostate, the majority
of PC cases are diagnosed at an early stage
(60). As PC is slow growing, many patients can
leave their disease untreated for extended
periods of time with frequent monitoring
(watchful waiting or active surveillance), with
many patients dying from other causes before
treatment is indicated. Surgery and/or
radiotherapy is often curative when treatment is
indicated for localized disease, with androgen
deprivation being the standard of first-line
care. The current late-stage drugs in
development for PC address this clinical need,
however, results so far have been mixed, with
none demonstrating clinically transformative
efficacy of safety. As a result, the growth in PC
prevalence as a result of a global aging
population is expected to be the key driver of
this market throughout the forecast period.
Click Here To Check Complete Report
3
  • Scope of the Report
  • Global revenues for the PC market are forecast to
    rise at a moderate CAGR of 9.5 from 7.6bn in
    2014 to 13.6bn in 2021.
  • What factors are driving the market growth?
  • How can the factors limiting growth be overcome
    in the future?
  • The pipeline addresses clinical need in the
    market seven of the nine late-stage pipeline
    products are being developed as therapies for
    metastatic castration resistant disease.
  • What other gaps in the market are being addressed
    by the current pipeline dynamics?
  • The variation in molecule type has shifted away
    from small molecules (predominately hormonal
    therapies), the dominance of which has decreased
    from 91 across marketed products to 50 across
    the pipeline.
  • How does this reflect the need for novel targeted
    therapies?
  • There has been a significant shift away from
    hormonal therapies. Key mechanisms of action
    across the pipeline include cancer
    immunotherapies against PSMA, whole cell vaccines
    and targeted therapies against the PI3K/Akt/mTOR
    pathway.

Download Sample Brochure
4
  • Reasons to buyThis report will allow you to -
  • Understand the current clinical and commercial
    landscape by considering disease pathogenesis,
    diagnosis, prognosis, and the treatment options
    available at each stage of diagnosis.
  • Visualize the composition of the PC market in
    terms of dominant molecule types and targets,
    highlighting the current unmet needs and how they
    can be addressed to allow a competitive
    understanding of gaps in the current market.
  • Analyze the PC pipeline and stratify by stage of
    development, molecule type, and molecular target.
  • Visualize the clinical safety and efficacy of
    late-stage pipeline drugs via a detailed heat
    map, outlining the results across major clinical
    trial endpoints.
  • Understand the growth in patient epidemiology,
    annual therapy costs, and market revenues for the
    AML market globally and across the US, UK,
    France, Germany, Italy, Spain, Japan, and Canada.
  • Identify commercial opportunities in the PC deals
    landscape by analyzing trends in licensing and
    co-development deals.

Make an Inquiry Before Buying
5
Prostate Cancer Market to 2021 - Increasing
Disease Prevalence to be a Key Driver of Market
Growth
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
Prostate Cancer Market to 2021 - Increasing
Disease Prevalence to be a Key Driver of Market
Growth are provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Prostate Cancer
Market Report
Write a Comment
User Comments (0)
About PowerShow.com